BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2941187)

  • 1. Gonadal and adrenal androgen secretion in hirsute females.
    Molta L; Schwartz U
    Clin Endocrinol Metab; 1986 May; 15(2):229-45. PubMed ID: 2941187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adrenal cortex and virilization.
    McKenna TJ; Cunningham SK; Loughlin T
    Clin Endocrinol Metab; 1985 Nov; 14(4):997-1020. PubMed ID: 3002682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic evaluation of hirsutism in women.
    Farber M; Millan VG; Turksoy RN; Mitchell GW
    Clin Obstet Gynecol; 1977 Mar; 20(1):1-9. PubMed ID: 837574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hirsutism.
    Mauvais-Jarvis P; Kuttenn F; Mowszowicz I
    Monogr Endocrinol; 1981; 19():1-116. PubMed ID: 6454061
    [No Abstract]   [Full Text] [Related]  

  • 5. Ovarian and adrenal vein steroids in seven patients with androgen-secreting ovarian neoplasms: selective catheterization findings.
    Moltz L; Pickartz H; Sörensen R; Schwartz U; Hammerstein J
    Fertil Steril; 1984 Oct; 42(4):585-93. PubMed ID: 6237938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovarian disease: the adrenal connection.
    Marouliss GB; Triantafillidis IK
    Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():205-7. PubMed ID: 16641861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
    Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hirsutism and virilism in women.
    Kirschner MA
    Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The origin of androgen synthesis in polycystic ovary syndrome.
    Milewicz A; Silber D; Mielecki T
    Obstet Gynecol; 1983 Nov; 62(5):601-4. PubMed ID: 6225965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
    Rittmaster RS; Thompson DL
    J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroids, adiposity and smoking in the pathogenesis of idiopathic hirsutism and polycystic ovary syndrome.
    Byrne B; Cunningham S; Igoe D; Conroy R; McKenna TJ
    Acta Endocrinol (Copenh); 1991 Apr; 124(4):370-4. PubMed ID: 1827700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens in women: Androgen-mediated skin disease and patient evaluation.
    Bienenfeld A; Azarchi S; Lo Sicco K; Marchbein S; Shapiro J; Nagler AR
    J Am Acad Dermatol; 2019 Jun; 80(6):1497-1506. PubMed ID: 30312644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian and adrenal contributions to peripheral androgens in hirsute women.
    Abraham GE; Chakmakjian ZH; Buster JE; Marshall JR
    Obstet Gynecol; 1975 Aug; 46(2):169-73. PubMed ID: 125398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen production in women.
    Burger HG
    Fertil Steril; 2002 Apr; 77 Suppl 4():S3-5. PubMed ID: 12007895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgens in Menopausal Women: Not Only Polycystic Ovary Syndrome.
    Kostakis EK; Gkioni LN; Macut D; Mastorakos G
    Front Horm Res; 2019; 53():135-161. PubMed ID: 31499509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adrenal and ovarian steroid hormone responses to gonadotropin-releasing hormone agonist treatment in polycystic ovary syndrome.
    Gonzalez F; Hatala DA; Speroff L
    Am J Obstet Gynecol; 1991 Sep; 165(3):535-45. PubMed ID: 1832519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenal and gonadal androgen secretion in normal females.
    Longcope C
    Clin Endocrinol Metab; 1986 May; 15(2):213-28. PubMed ID: 3013468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppressibility and adrenal and ovarian venous effluents of 5α-reduced C19 conjugates in hyperandrogenic women.
    Stanczyk FZ; Saxena T; Lobo RA
    J Steroid Biochem Mol Biol; 2014 Jan; 139():73-7. PubMed ID: 24121067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
    Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
    Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF).
    De Leo V; la Marca A; Lanzetta D; Cariello PL; D'Antona D; Morgante G
    Clin Endocrinol (Oxf); 1998 Jul; 49(1):85-9. PubMed ID: 9797851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.